Mdm2 links genotoxic stress and metabolism to p53

被引:22
|
作者
Wang, Zhongfeng [1 ]
Li, Baojie [1 ]
机构
[1] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Ctr, Shanghai 200240, Peoples R China
关键词
mouse double minute 2 (Mdm2); p53; signal transduction; tumorigenesis;
D O I
10.1007/s13238-010-0140-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mouse double minute 2 (Mdm2) gene was isolated from a cDNA library derived from transformed mouse 3T3 cells, and was classified as an oncogene as it confers 3T3 and Rat2 cells tumorigenicity when overexpressed. It encodes a nucleocytoplasmic shuttling ubiquitin E3 ligase, with its main target being tumor suppressor p53, which is mutated in more than 50% of human primary tumors. Mdm2's oncogenic activity is mainly mediated by p53, which is activated by various stresses, especially genotoxic stress, via Atm (ataxia telangiectasia mutated) and Atr (Atm and Rad3-related). Activated p53 inhibits cell proliferation, induces apoptosis or senescence, and maintains genome integrity. Mdm2 is also a target gene of p53 transcription factor. Thus, Mdm2 and p53 form a feedback regulatory loop. External and internal cues, through multiple signaling pathways, can act on Mdm2 to regulate p53 levels and cell proliferation, death, and senescence. This review will focus on how Mdm2 is regulated under genotoxic stress, and by the Akt1-mTOR-S6K1 pathway that is activated by insulin, growth factors, amino acids, or energy status.
引用
收藏
页码:1063 / 1072
页数:10
相关论文
共 50 条
  • [41] Mdm2 gene amplification in gastric cancer correlation with expression of mdm2 protein and p53 alterations
    Günther, T
    Schneider-Stock, R
    Häckel, C
    Kasper, HU
    Pross, M
    Hackelsberger, A
    Lippert, H
    Roessner, A
    MODERN PATHOLOGY, 2000, 13 (06) : 621 - 626
  • [42] The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
    Huang, Lei
    Yan, Zheng
    Liao, Xiaodong
    Li, Yuan
    Yang, Jie
    Wang, Zhu-Gang
    Zuo, Yong
    Kawai, Hidehiko
    Shadfan, Miriam
    Ganapathy, Suthakar
    Yuan, Zhi-Min
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 12001 - 12006
  • [43] p53 mRNA and p53 Protein Structures Have Evolved Independently to Interact with MDM2
    Karakostis, Konstantinos
    Ponnuswamy, Anand
    Fusee, Leila T. S.
    Bailly, Xavier
    Laguerre, Laurent
    Worall, Erin
    Vojtesek, Borek
    Nylander, Karin
    Fahraeus, Robin
    MOLECULAR BIOLOGY AND EVOLUTION, 2016, 33 (05) : 1280 - 1292
  • [44] Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors
    Yokoyama, R
    Schneider-Stork, R
    Radig, K
    Wex, T
    Roessner, A
    PATHOLOGY RESEARCH AND PRACTICE, 1998, 194 (09) : 615 - 621
  • [45] MDM2 and MDM4: p53 regulators as targets in anticancer therapy
    Toledo, Franck
    Wahl, Geoffrey M.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8) : 1476 - 1482
  • [46] CacyBP/SIP protein reduces p53 stability by enhancing Mdm2 activity in p53 mutant glioma cells
    Qian, Fengyuan
    Tang, Tianjin
    Wang, Shiquan
    Wang, Bin
    Wang, Lei
    Shi, Hengliang
    NEOPLASMA, 2021, 68 (01) : 119 - 125
  • [47] Rapamycin increases the p53/MDM2 protein ratio and p53-dependent apoptosis by translational inhibition of mdm2 in cancer cells
    Kao, Chia-Li
    Hsu, Han-Shui
    Chen, Hsin-Wu
    Cheng, Tzu-Hao
    CANCER LETTERS, 2009, 286 (02) : 250 - 259
  • [48] p53 and MDM2 immunostaining in pulmonary blastomas and bronchogenic carcinomas
    Pacinda, SJ
    Ledet, SC
    Gondo, MM
    Langston, C
    Brown, RW
    Carmona, PA
    Franklin, RB
    Roggli, VL
    Cagle, PT
    HUMAN PATHOLOGY, 1996, 27 (06) : 542 - 546
  • [49] p53/MDM2 signaling pathway in aging, senescence and tumorigenesis
    Huang, Youyi
    Che, Xiaofang
    Wang, Peter W.
    Qu, Xiujuan
    SEMINARS IN CANCER BIOLOGY, 2024, 101 : 44 - 57
  • [50] Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway
    Twala, Charmy
    Malindisa, Sibusiso
    Munnik, Chamone
    Sooklal, Selisha
    Ntwasa, Monde
    BIOMEDICINES, 2025, 13 (01)